三月 2026
- Home
- Triad Life Sciences, Inc.
三月 2026的Triad Life Sciences, Inc.市场份额分析
We cannot find the page you are looking for. Please check if the web address is correct or try to access the page directly from Convatec.com.
Triad Life Sciences, Inc.(包含公司地区分支机构)
查看更多网站流量和参与度信息- triadls.com
Triad Life Sciences, Inc.收入截至 三月 2026为 25M - 50M
Triad Life Sciences, Inc.主要域名产生的收入
3 年中Triad Life Sciences, Inc.主要域名的收入
Triad Life Sciences, Inc.主要域名的收入
Triad Life Sciences, Inc.热门域名的总访问量
了解Triad Life Sciences, Inc.市场份额和潜在市场覆盖范围。
过去 3 个月的总访问量
无数据可显示
无数据可显示
Triad Life Sciences, Inc.热门域名的平均访问时长
分析Triad Life Sciences, Inc.参与度指标。
过去 3 个月的平均访问时长
无数据可显示
无数据可显示
Triad Life Sciences, Inc.热门域名的平均页面浏览量
了解Triad Life Sciences, Inc.如何保持用户参与度、培养用户兴趣和鼓励采取后续操作。
过去 3 个月的平均页面浏览量
无数据可显示
无数据可显示
想要获取更深入的流量洞见?
过滤超过 2030 万家在线企业。发现流量激增的新潜在客户,开始或停止使用技术的新潜在客户,或者获得正面报道的新潜在客户。
Triad Life Sciences, Inc. 的新闻与信号
借助 Similarweb 销售信号提醒,每当在目标受众之中出现新的机会或威胁时,您都会收到所识别出购买信号的每日更新。
新闻ConvaTec Group acquired Triadls for $450M on Jan 1st '22.Total medical devices industry cross border M&A deals worth $592.6m were announced globally in January 2022, led by ConvaTec Group’s $450m acquisition of Triad Life Sciences, according to GlobalData’s deals database.
二月 18, 2022阅读更多
新闻ConvaTec acquired Triadls for $275M on Jan 1st '22.(Sharecast News) - Medical solutions firm Convatec has agreed to acquire US-focussed medical device company Triad Life Sciences in a deal worth as much as $275.0m.
一月 27, 2022阅读更多
新闻Triadls goes public.Regenerative medicine biotech Triad Life Sciences has postponed IPO discussions after receiving a takeover bid from a strategic player for a 30 per cent premium.
十一月 14, 2021阅读更多
查看 Triad Life Sciences, Inc. 的所有信号
让您的销售团队专注于最有希望的机会。通过分清机会的轻重缓急并在合适的时机介入,您可以优化工作并达成更多交易。